288 related articles for article (PubMed ID: 29685291)
21. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies.
Coesmans M; Smitt PA; Linden DJ; Shigemoto R; Hirano T; Yamakawa Y; van Alphen AM; Luo C; van der Geest JN; Kros JM; Gaillard CA; Frens MA; de Zeeuw CI
Ann Neurol; 2003 Mar; 53(3):325-36. PubMed ID: 12601700
[TBL] [Abstract][Full Text] [Related]
23. [A case of anti-gliadin-antibody-positive cerebellar ataxia effectively treated with intravenous immunoglobulin in which voxel-based morphometry and FineSRT were diagnostically useful].
Nanri K; Otsuka T; Takeguchi M; Taguchi T; Ishiko T; Mitoma H; Koizumi K
Rinsho Shinkeigaku; 2009 Jan; 49(1):37-42. PubMed ID: 19227895
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
25. Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies.
Gollion C; Dupouy J; Roberts M; Simonetta-Moreau M; Brefel Courbon C; Rascol O; Honnorat J; Magne FO
Mov Disord; 2019 Mar; 34(3):438-439. PubMed ID: 30759326
[No Abstract] [Full Text] [Related]
26. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
[TBL] [Abstract][Full Text] [Related]
27. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
Pedroso JL; Braga-Neto P; Dutra LA; Barsottini OG
Arq Neuropsiquiatr; 2011 Dec; 69(6):993. PubMed ID: 22297896
[No Abstract] [Full Text] [Related]
28. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
Aguiar TS; Fragoso A; Albuquerque CR; Teixeira PF; Souza MV; Zajdenverg L; Alves-Leon SV; Rodacki M; Lima MA
Arq Neuropsiquiatr; 2017 Mar; 75(3):142-146. PubMed ID: 28355320
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
[TBL] [Abstract][Full Text] [Related]
30. Neuronal antibodies in nonparaneoplastic autoimmune cerebellar ataxias.
Saiz A; Graus F
Curr Opin Neurol; 2024 Jun; 37(3):322-328. PubMed ID: 38483149
[TBL] [Abstract][Full Text] [Related]
31. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report.
Mélé N; Hautefort C; Toledano A; Delattre JY; Psimaras D
J Neurol; 2016 Feb; 263(2):405-406. PubMed ID: 26754007
[No Abstract] [Full Text] [Related]
33. Anti-Sez6l2 antibody detected in a patient with immune-mediated cerebellar ataxia inhibits complex formation of GluR1 and Sez6l2.
Yaguchi H; Yabe I; Takahashi H; Watanabe M; Nomura T; Kano T; Watanabe M; Hatakeyama S
J Neurol; 2018 Apr; 265(4):962-965. PubMed ID: 29423613
[No Abstract] [Full Text] [Related]
34. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
35. Recoverin antibody-associated late-onset ataxia without retinopathy.
Herzog R; Brüggemann N; Sprenger A; Münte TF
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33334756
[TBL] [Abstract][Full Text] [Related]
36. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy for autoimmune autonomic ganglionopathy.
Iodice V; Kimpinski K; Vernino S; Sandroni P; Low PA
Auton Neurosci; 2009 Mar; 146(1-2):22-5. PubMed ID: 19056323
[TBL] [Abstract][Full Text] [Related]
38. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
39. Cerebellar ataxia with anti-mGluR1 auto-antibody in a pediatric patient: A case report.
Wang H; Yi B; Wang M; Wang Y; Wang S; Wang L; Song H; Fu J; Wang X; Cao L
J Neuroimmunol; 2023 May; 378():578082. PubMed ID: 37119682
[TBL] [Abstract][Full Text] [Related]
40. Anti-mGluR1 encephalitis: Case illustration and systematic review.
Khojah O; Makkawi S; Alghamdi S
Front Neurol; 2023; 14():1142160. PubMed ID: 37139064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
